Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

February 28, 2007

Study Completion Date

November 30, 2008

Conditions
Vitreomacular Traction MaculopathyEye Diseases
Interventions
DRUG

Microplasmin

25ug injected 1 hr prior to PPV, 24 hr and 7 days prior to PPV, 50ug injected 24 hr prior to PPV, 75ug injected 24 hr prior to PPV and 125ug injected 24 hr prior to PPV.

Trial Locations (3)

B-3000

University Hospital Gasthuisberg, Leuven

1105 AZ

Academic Medical Center, University of Amsterdam, Amsterdam

3011 BH

Oogziekenhuis Rotterdam, Rotterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ThromboGenics

INDUSTRY

NCT00123279 - Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy | Biotech Hunter | Biotech Hunter